Exascale Labs Holdings Inc. (XLAB) stock
XLABNasdaqServices-Prepackaged SoftwareFiscal year ends June 30Also trades as XLABW
$2.14−0.13 (-5.73%)
Close on Nov 13, 2026Market cap $137.68MP/E –Yield –
Exascale Labs r&d expenses
Research and development expenses are spending on new products and technology.
For fiscal 2026 it was $5.49M, up 96.2% from the year before.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $5.49M | +96.2% |
| FY2025 | Jun 30, 2025 | $2.80M | – |
See a number that looks wrong?